Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Triazolam price, strengths & recalls

Pharmacies pay $9.97 for 30 tablets of Triazolam 0.25 mg tablet this week, and from $8.40 to $9.97 across its 2 priced strengths and forms. 8 manufacturers make it. Its official label last changed on August 30, 2024.

Generic
Pharmacies pay$9.97for 30 tablets of 0.25 mg tablet+7.8% in 4 weeks
Fair cash price
$21.97
Strengths
2
Makers
8
Updated
Nov 11

Triazolam price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.125 mg tablet$0.2799$8.40 / 30 tablets+6.5%-28.8%
0.25 mg tablet$0.3325$9.97 / 30 tablets+7.8%-1.4%

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for triazolam? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 30, 2024
Version103 of 4
EffectiveAug 28, 2024
Read the label

These highlights do not include all the information needed to use TRIAZOLAM TABLETS safely and effectively. See full prescribing information for TRIAZOLAM TABLETS. TRIAZOLAM tablets, for oral use, CIVInitial U.S. Approval: 1982

This drug has a boxed warning

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings and Precautions (5.1), Drug Interactions (7.1)].

The use of benzodiazepines, including triazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing triazolam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].

The continued use of benzodiazepines, including triazolam, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of triazolam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue triazolam or reduce the dosage [see Dosage and Administration (2.3), Warnings and Precautions (5.3)].

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

See full prescribing information for complete boxed warning.

Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (5.1, 7.1).

The use of benzodiazepines, including triazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing triazolam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction (5.2).

Abrupt discontinuation or rapid dosage reduction of triazolam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue triazolam or reduce the dosage (2.3, 5.3).

Recent major changes (as listed on the label)

Boxed Warning 2/2021

Dosage and Administration (2.3) 2/2021

Warnings and Precautions (5.2, 5.3) 2/2021

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA017892 · Pfizer
First approved
November 15, 1982 (44 years ago)
Latest approved change
January 13, 2023
Approved label
PDF, Jan 17, 2023
Generic makers
2 approved generic applications on the market

Triazolam questions

How much does triazolam cost without insurance?

Pharmacies pay about $9.97 for 30 tablets of triazolam 0.25 mg tablet ($0.3325 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $21.97. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is triazolam in shortage?

No shortage is reported for triazolam right now. We check the national shortage list every day.

Has triazolam been recalled?

No recalls are on record for triazolam.

When did the triazolam label last change?

The official label was last updated on August 30, 2024 (version 103). See what changed.

Talk about triazolam

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.